Home Markets Amgen says experimental obesity drug has promising durability

Amgen says experimental obesity drug has promising durability

Dec 04, 2022 comments off

Original source: https://www.investing.com/news/stock-market-news/amgen-says-experimental-obesity-drug-has-promising-durability-2956824

You May Also Like

Qantas to close low-cost arm Jetstar Asia and cycle $326.4 million of capital

China’s saucemaker Foshan Haitian to raise $1.2 bln in Hong Kong IPO

India’s Maruti Suzuki cuts near-term EV production amid rare earths crisis

Mexico stocks higher at close of trade; S&P/BMV IPC up 0.49%

Starbucks accelerates new staffing model to all North American stores

US senators grill Trump CFTC nominee over industry ties, commission vacancies